Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jian Chu
Institutions:
Zhejiang Chinese Medical University,
Huzhou Normal University,
Huzhou Central Hospital,
China Medical University
Observed institutions:
Zhejiang Chinese Medical University,
Huzhou Normal University,
Huzhou Central Hospital,
China Medical University
ORCID:
0000-0003-0817-1149
Observed ORCID:
0000-0003-0817-1149
OpenAlex ID:
A5136209895
Bacterial ghosts: A promising new tool for biomedical applications
2026
·
Zheng Wu
, Yinhang Wu
, et al.
·
Genes & Diseases
·
3
Figure S5 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Data from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S7 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S6 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S3 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Supplementary Tables from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S2 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S4 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S8 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Figure S1 from Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
2026
·
Jing Mao
, Xu Sun
, et al.
·
Cancer Immunology Research
Single-cell dissection of cholesterol metabolism reveals cell-type-specific genes and hypercholesterolemia-associated remodeling
2026
·
Jian Chu
, Jing Zhuang
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
Single-cell dissection of cholesterol metabolism reveals cell-type-specific genes and hypercholesterolemia-associated remodeling
2026
·
Jian Chu
, Jing Zhuang
, et al.
·
ScienceDB
Decoding the human gut bacterial plasmids in colorectal cancer
2026
·
Shuwen Han
, Zheng Wu
, et al.
·
Communications Biology
PDF
Show more works
View as search
Works count:
15
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type